Skip to main content

Disclaimer

In the Downloads section, the ‘Prior Submission’ file reflects the most recent measure submission to the former CBE. This file is provided for transparency. For any questions or clarification, please contact the designated measure steward.

Hemodialysis Vascular Access: Standardized Fistula Rate

CBE ID
2977
1.5 Project
Endorsement Status
1.0 New or Maintenance
1.1 Measure Structure
Previous Endorsement Cycle
Is Under Review
No
1.6 Measure Description

Adjusted percentage of adult hemodialysis patient-months using an autogenous arteriovenous fistula (AVF) as the sole means of vascular access.

    Measure Specs
      General Information
      1.7 Measure Type
      1.3 Electronic Clinical Quality Measure (eCQM)
      No
      1.8 Level of Analysis
      1.9 Care Setting
      1.20 Types of Data Sources
      1.14 Numerator

      The numerator is the adjusted count of adult patient-months using an AVF as the sole means of vascular access as of the last hemodialysis treatment session of the month.

      1.15 Denominator

      All patient-months for patients at least 18 years old as of the first day of the reporting month who are determined to be maintenance hemodialysis patients (in-center and home HD) for the entire reporting month at the same facility.

      When used for public reporting, the measure calculation will be restricted to facilities with at least 11 patients in the reporting month. This restriction is required to ensure patients cannot be identified due to small cell size.

      Exclusions

      Exclusions that are implicit in the denominator definition include:
      • Pediatric patients (<18 years old)
      • Patients on Peritoneal Dialysis
      • Patient-months with in-center or home hemodialysis for less than a complete reporting month at the same facility

      In addition, the following exclusions are applied to the denominator:
      Patients with a catheter that have limited life expectancy:
      • Patients under hospice care in the current reporting month
      • Patients with metastatic cancer in the past 12 months
      • Patients with end stage liver disease in the past 12 months
      • Patients with coma or anoxic brain injury in the past 12 months

      Most Recent Endorsement Activity
      Measure Retired and Endorsement Removed Renal Spring Cycle 2020
      Initial Endorsement
      Last Updated
      Removal Date
      Steward Organization
      Centers for Medicare & Medicaid Services
      Steward POC email
              Risk Adjustment
                Use
                6.1.2 Current or Planned Use(s)
                6.1.3 Current or Planned Use(s)
                  Public Comments